ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,127.79
      0.00%
      US Tech 100
      17,481.96
      0.36%
      Dow Jones
      38,675.68
      0.00%
      Brent Oil
      83.375
      0.30%
      Bitcoin
      63,543.98
      -0.71%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Veru Inc (VERU)

      7. Veru Inc (VERU) News

      VERU

      Veru (VERU)

      Veru Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:VERU
      DateTimeSourceHeadlineSymbolCompany
      05/02/20248:30AMGlobeNewswire Inc.Veru to Present at the GLP-1 Based Therapeutics SummitNASDAQ:VERUVeru Inc
      05/01/20248:30AMGlobeNewswire Inc.Veru to Report Fiscal 2024 Second Quarter Financial Results on May 8, 2024NASDAQ:VERUVeru Inc
      04/30/20248:30AMGlobeNewswire Inc.Veru Enrolls First Patients in Phase 2b Clinical Trial of Enobosarm and Semaglutide Combination for High Quality Weight LossNASDAQ:VERUVeru Inc
      04/25/20248:30AMGlobeNewswire Inc.Veru to Present at the American Association of Clinical Endocrinology (AACE) 2024 Annual Meeting on May 9-11NASDAQ:VERUVeru Inc
      04/01/20244:05PMGlobeNewswire Inc.Veru Announces Date of 2024 Annual Meeting of ShareholdersNASDAQ:VERUVeru Inc
      03/22/20244:05PMGlobeNewswire Inc.Veru Reschedules Annual Meeting of ShareholdersNASDAQ:VERUVeru Inc
      03/12/20248:00AMGlobeNewswire Inc.Veru Announces the Appointment of Louis Aronne MD as Chief Medical Advisor for its Enobosarm Program for High Quality Weight LossNASDAQ:VERUVeru Inc
      02/27/20247:15PMGlobeNewswire Inc.Veru Announces Notification from Nasdaq Related to Delayed Quarterly Report on Form 10-QNASDAQ:VERUVeru Inc
      02/20/20248:30AMGlobeNewswire Inc.Veru Announces New Scientific Advisory Board for its Enobosarm Program for High Quality Weight LossNASDAQ:VERUVeru Inc
      02/15/20244:49PMEdgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBNASDAQ:VERUVeru Inc
      02/15/20244:06PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:VERUVeru Inc
      02/14/20244:32PMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:VERUVeru Inc
      02/08/20247:00AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:VERUVeru Inc
      02/08/20246:30AMGlobeNewswire Inc.Veru Reports Fiscal 2024 First Quarter Financial HighlightsNASDAQ:VERUVeru Inc
      02/06/20244:27PMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:VERUVeru Inc
      02/06/20248:30AMGlobeNewswire Inc.Veru Announces FDA Clearance of IND Application to Initiate Phase 2b Clinical Trial with Enobosarm to Treat Muscle Loss Associated with Weight Loss DrugsNASDAQ:VERUVeru Inc
      01/31/20248:30AMGlobeNewswire Inc.Veru to Present at the Oppenheimer 34th Annual Healthcare Life Sciences ConferenceNASDAQ:VERUVeru Inc
      01/26/20244:06PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:VERUVeru Inc
      01/26/20249:02AMEdgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:VERUVeru Inc
      01/26/20249:00AMEdgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:VERUVeru Inc
      01/25/20248:30AMGlobeNewswire Inc.Veru to Report Fiscal 2024 First Quarter Financial Results on February 8, 2024NASDAQ:VERUVeru Inc
      01/08/20248:30AMGlobeNewswire Inc.Veru Submits IND Application to FDA for the Development of Enobosarm to Prevent Muscle Loss While Augmenting Fat Loss in Combination with GLP-1 Drugs for Weight LossNASDAQ:VERUVeru Inc
      12/26/20234:31PMEdgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:VERUVeru Inc
      12/19/20238:30AMGlobeNewswire Inc.Veru to Host Investor Call on January 4th, 2024 to Discuss Recent Financing and Strategy to Prioritize the Development of Enobosarm as a Combination Treatment to Prevent Muscle Loss and Augment Fat Loss Associated with Weight Loss GLP-1 DrugsNASDAQ:VERUVeru Inc
      12/18/20239:01AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:VERUVeru Inc
      12/15/20234:04PMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:VERUVeru Inc
      12/14/20239:00AMGlobeNewswire Inc.Veru Announces Pricing of Public Offering of Common StockNASDAQ:VERUVeru Inc
      12/13/20234:23PMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:VERUVeru Inc
      12/13/20234:06PMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:VERUVeru Inc
      12/13/20234:04PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:VERUVeru Inc
       Showing the most relevant articles for your search:NASDAQ:VERU